phyllanthoside: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 100992284 |
| MeSH ID | M0063546 |
| Synonym |
|---|
| phyllanthoside |
| nsc-328426 |
| 63166-73-4 |
| ccris 670 |
| beta-d-glucopyranose, 2-o-(3-o-acetyl-6-deoxy-beta-d-glucopyranosyl)-6-deoxy-, 3-acetate 1-(decahydro-5''-methyl-4''-((1-oxo-3-phenyl-2-propenyl)oxy)dispiro(oxirane-2,3'(2'h)-benzofuran)-2',2''-(2h)pyran-6'-carboxylate), (2's-(2'-alpha(4''r*(e),5''s*),3'- |
| beta-d-glucopyranose, 2-o-(3-o-acetyl-6-deoxy-beta-d-glucopyranosyl)-6-deoxy-, 3-acetate 1-(decahydro-5''-methyl-4''-((1-oxo-3-phenyl-2-propenyl)oxy)dispiro(oxirane-2,3'(2'h)-benzofuran-2',2''-(2h)pyran)-6'-carboxylate), (2's-(2'alpha(4''r*(e),5''s*),3'be |
| nsc 328426 |
| phylanthoside |
| unii-5lv0n6k0ca |
| 5lv0n6k0ca , |
| .beta.-d-glucopyranose, 2-o-(3-o-acetyl-6-deoxy-.beta.-d-glucopyranosyl)-6-deoxy-, 3-acetate 1-((2r,2's,3'as,4''s,5''r,6's,7'ar)-decahydro-5''-methyl-4''-(((2e)-1-oxo-3-phenyl-2-propen-1-yl)oxy)dispiro(oxirane-2,3'(2'h)-benzofuran-2',2''-(2h)pyran)-6'-car |
| DTXSID601031618 |
Phyllanthoside is a naturally occurring glycoside with activity against IP transplantable murine tumors. It is isolated from the roots of the Central American tree Phyllanthus acuminatus Vahl.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Phyllanthoside is a naturally occurring glycoside with activity against IP transplantable murine tumors. " | ( Disposition and metabolism of the antitumor glycoside phyllanthoside in mouse and beagle dog. Moore, DJ; Powis, G, 1986) | 1.96 |
| "Phyllanthoside is a glycoside isolated from the roots of the Central American tree Phyllanthus acuminatus Vahl with antitumor activity against murine B-16 melanoma and P-388 leukemia. " | ( High-performance liquid chromatographic assay for the antitumor glycoside phyllanthoside and its stability in plasma of several species. Moore, DJ; Powis, G, 1985) | 1.94 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.19) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||